China Shineway Pharmaceutical Group Limited (FRA:C1S)

Germany flag Germany · Delayed Price · Currency is EUR
0.9950
+0.0650 (6.99%)
At close: Mar 27, 2026
Market Cap770.19M -0.2%
Revenue (ttm)381.80M -17.0%
Net Income115.67M +13.1%
EPS0.15 +13.3%
Shares Outn/a
PE Ratio6.66
Forward PE7.34
Dividend0.06 (5.69%)
Ex-Dividend DateSep 9, 2025
Volumen/a
Average Volume29
Open1.0100
Previous Close0.9300
Day's Range0.9950 - 1.0100
52-Week Range0.7850 - 1.0700
Betan/a
RSI53.29
Earnings DateMar 27, 2026

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 2,867
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C1S

Financial Performance

In 2025, FRA:C1S's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements